Treatment of sarcopenia and glucose intolerance through mitochondrial activation by 5-aminolevulinic acid
Abstract Recently, sarcopenia has attracted attention as therapeutic target because it constitutes a risk factor for metabolic and cardiovascular diseases. We focused 5-aminolevulinic acid (ALA) which act as electron carriers in the mitochondrial electron transport system. The mice that received ALA...
Guardado en:
Autores principales: | Chikako Fujii, Kazutoshi Miyashita, Masanori Mitsuishi, Masaaki Sato, Kentaro Fujii, Hiroyuki Inoue, Aika Hagiwara, Sho Endo, Asuka Uto, Masaki Ryuzaki, Motowo Nakajima, Tohru Tanaka, Masanori Tamaki, Ayako Muraki, Toshihide Kawai, Hiroshi Itoh |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3bbd0cbf26ea4990bafd6f92fe58cde9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Effects of 5-aminolevulinic acid supplementation on home-based walking training achievement in middle-aged depressive women: randomized, double-blind, crossover pilot study
por: Hiroshi Suzuki, et al.
Publicado: (2018) -
Author Correction: 5-aminolevulinic acid-mediated photodynamic therapy can target aggressive adult T cell leukemia/lymphoma resistant to conventional chemotherapy
por: Yasuhisa Sando, et al.
Publicado: (2021) -
Overcoming the Polemics of Intolerance
por: Louay M. Safi
Publicado: (2002) -
Rolling Contact Fatigue Life of Cavitation-Peened Steel Gear
por: Masanori Seki, et al.
Publicado: (2008) -
Treating statin-intolerant patients
por: Pigna G, et al.
Publicado: (2011)